UTHR vs VSTD · P/E 20, rev $2.88B vs rev $12.8M
United Therapeutics Corporation (UTHR) versus Vestand Inc. (VSTD) — a side-by-side from cached financials, not a winner call.
United Therapeutics Corporation (UTHR) is a drug manufacturers - specialty & generic company listed on NASDAQ.
Vestand Inc. (VSTD) is a restaurants company listed on NASDAQ.
Latest reported UTHR revenue for 2024-12-31 was $2.88B. Net income was $1.20B. Revenue was up 23.6% from 2023-12-31 to 2024-12-31. UTHR currently screens at market cap $23.41B and trailing P/E 20.4.
Latest reported VSTD revenue for 2024-12-31 was $12.8M. Net income was -$2.7M. Revenue was up 39.3% from 2023-12-31 to 2024-12-31. VSTD currently screens at market cap $4.5M.
UTHR currently screens at market cap $23.41B and trailing P/E 20.4. VSTD currently screens at market cap $4.5M.
Not investment advice. Open the UTHR and VSTD stock pages for the full models.
Not investment advice.